Nonetheless, it has been reported that lymphoma lesions, such as mutant EZH2 (enhancer of zeste homolog 2) in follicular lymphoma (FL), can override the p53-mediated induction of Sestrin1. The gene discussed is EZH2; the disease is follicular lymphoma.